point slew lawsuits facing manufacturers atypical antipsychotics individual suits ranging suits brought state governments allegations fraudulent marketing kickbacks hiding research results among claims made suits example arkansas recently filed lawsuit read read take important thing could come suits long run money various drug companies may shell fines important piece information internal documents i nearly certain document numerous instances demonstrating bad science covering negative data detailing ludicrous marketing campaigns check documents zyprexa furious seasons get taste i mean i written occasions others one monster post furious seasons serving excellent example documents companies engaged ethically dubious practices become public information pr hit would enormous hell media may even wake run numerous stories issue imagine minutes panorama npr frontline news programs hitting one hard multiple occasions complicity academic psychiatry makes story yet fascinating i mentioned recently without academics pimping treatments well beyond scientifically justifiable medications would never achieved huge success rather dangerous group medicines used virtually every psychiatric disorder sun uses include bipolar disorder infants adhd dementia let put vulnerable individuals riskiest treatments despite clear evidence work particularly well indeed evidence efficacy medications short term treatment schizophrenia bipolar disorder small number trials even long term evidence efficacy indiscriminant use across board virtually every condition brings great shame upon psychiatry profession big pharma slick marketing strategies especially upon academic psychiatry morally bankrupt role group salespeople misrepresented scientific findings help promote drugs hopes may well fleeting various offending companies may decide settle cases nearly always means get keep dirty laundry private sad possibility mentioned furious seasons risperdal goes patent one month except extra short lived pediatric indications i sure janssen huge incentive fight arkansas states suing order protect soon generic product likely much cheaper companies settle case liability insurance cover much cost write agreement admit fault manage deep six documents evidence bad behavior move onto invega zyprexa goes patent seroquel patent year well sure patents seroquel xr one wonders much incentive companies fight state suits whether settle cases move onto whatever next maybe i bit cynical would shock me things played lilly already settled billion lawsuits zyprexa stop unfortunately prognostication likely correct course insider astrazeneca janssen bristol myers squibb lilly pfizer though seems geodon received much legal attention decides leak aforementioned documents something consider open call insiders said companies email me peter rost philip dawdy ed silverman jack friday pharmagossip currently accepting insider documents regarding matters